Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: a pediatric oncology group study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples